Hvivo (HVO)

Sector:

Health Care

Index:

FTSE AIM All-Share

27.00p
   
  • Change Today:
      0.40p
  • 52 Week High: 30.50
  • 52 Week Low: 14.25
  • Currency: UK Pounds
  • Shares Issued: 680.37m
  • Volume: 1,575,036
  • Market Cap: £183.70m

hVIVO manufactures human challenge agent for Omicron

By Josh White

Date: Thursday 16 Mar 2023

LONDON (ShareCast) - (Sharecast News) - Specialist contract research organisation hVIVO has successfully manufactured its Omicron human challenge agent, it announced on Thursday.
The AIM-traded firm said the development expanded its portfolio to 11 human challenge models, for testing a broad range of infectious and respiratory disease products.

It said it was now actively offering Omicron human challenge trials as part of its service offering, and was in discussions with a number of existing and potential customers.

The board said the Omicron human challenge agent was developed with Vaxart, with the intent to conduct a subsequent Omicron human challenge study to test the efficacy of Vaxart's oral vaccine candidate.

However, Vaxart had announced its decision to postpone further clinical trials in its Covid-19 programme, including the challenge study, as it focussed on the development of an oral pan-betacoronavirus vaccine that could provide improved protection against SARS-CoV-2 and other types of betacoronaviruses.

"The Vaxart challenge study was not included in the company's order book and its postponement will have no impact on hVIVO's 2023 financial guidance," the board said in its statement.

"As at 31 December, the company's order book was £76m, with over 95% of forecasted revenue for 2023 contracted."

At the close on Thursday, shares in hVIVO were up 0.88% at 17.25p.

Reporting by Josh White for Sharecast.com.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Hvivo Market Data

Currency UK Pounds
Share Price 27.00p
Change Today 0.40p
% Change 1.50 %
52 Week High 30.50
52 Week Low 14.25
Volume 1,575,036
Shares Issued 680.37m
Market Cap £183.70m

Hvivo Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
95.77% below the market average95.77% below the market average95.77% below the market average95.77% below the market average95.77% below the market average
81.82% below the sector average81.82% below the sector average81.82% below the sector average81.82% below the sector average81.82% below the sector average
Price Trend
93.04% above the market average93.04% above the market average93.04% above the market average93.04% above the market average93.04% above the market average
94.44% above the sector average94.44% above the sector average94.44% above the sector average94.44% above the sector average94.44% above the sector average
Income
94.97% below the market average94.97% below the market average94.97% below the market average94.97% below the market average94.97% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
42.92% above the market average42.92% above the market average42.92% above the market average42.92% above the market average42.92% above the market average
77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average

What The Brokers Say

Strong Buy 3
Buy 3
Neutral 0
Sell 0
Strong Sell 0
Total 6
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Hvivo Dividends

  Latest Previous
  Final Special
Ex-Div 18-Apr-24 04-May-23
Paid 20-May-24 09-Jun-23
Amount 0.20p 0.45p

Trades for 29-May-2024

Time Volume / Share Price
14:26 379,777 @ 26.70p
16:35 2,837 @ 27.00p
16:35 1 @ 27.00p
16:35 2,836 @ 27.00p
16:33 319 @ 26.75p

Hvivo Key Personnel

CEO Yamin Mo' Khan

Top of Page